Abstract: Disclosed herein are immunogenic mutant Shiga-Like Toxin II variants and vaccines containing such toxins. The mutant toxin comprises an SLT-IIv where the amino acid at position 167 in the A subunit has been replaced by a differently charged amino acid that essentially maintains the structure of the native A subunit. In a preferred embodiment, the glutamic acid is replaced with glutamine. An analogous modification may also be made at position 170. The vaccines are used for edema disease of swine.
Type:
Grant
Filed:
January 10, 1994
Date of Patent:
September 3, 1996
Assignees:
MicroCarb, Inc., The United States of America as represented by the Secretary of the Army
Abstract: Disclosed herein are high titer, monospecific, polyclonal antibodies to Shiga-like toxins. Also disclosed are methods for producing such antibodies, compositions containing them, and methods for the diagnosis, prevention, and treatment of diseases caused by Shiga-like toxins. These include hemorrhagic colitis and hemolytic uremic syndrome in humans, edema disease in swine, and calf diarrhea in cattle.
Abstract: A variety of conjugates useful for the treatment of infections due to pathogenic microorganisms are provided. The conjugates comprise at least one agent coupled to a receptor which binds a microorganism. Suitable agents include anti-infectives, such as antibiotics and synthetic drugs. The present invention also provides methods for treating infections in warm-blooded animals due to pathogenic microorganisms.
Type:
Grant
Filed:
January 12, 1994
Date of Patent:
November 14, 1995
Assignee:
MicroCarb, Inc.
Inventors:
Howard C. Krivan, A. Lennart I. Blomberg
Abstract: Methods for the in vitro and in vivo inhibition of microbial colonization are provided. The methods use host cell phospholipid molecules ("receptors") which bind microorganisms.
Type:
Grant
Filed:
June 16, 1993
Date of Patent:
May 2, 1995
Assignees:
HCS Research and Development, MicroCarb, Inc.
Inventors:
Clifford A. Lingwood, Howard C. Krivan, Bo Nilsson